Oflomac OZ Tablet

Oflomac OZ Tablet is a combination antibiotic containing Ofloxacin (200mg) and Ornidazole (500mg). It is widely used to treat gastrointestinal infections caused by bacteria and protozoa, especially when diarrhea or dysentery is due to mixed pathogens.

  • Ofloxacin is a fluoroquinolone antibiotic effective against a broad range of bacteria by inhibiting bacterial DNA replication.

  • Ornidazole is an antiprotozoal and antibacterial agent effective against anaerobic bacteria and protozoa like amoeba and giardia.

Together, this combination provides a synergistic effect, making it effective in mixed bacterial and protozoal infections.

Common Uses:

  • Acute diarrhea and dysentery

  • Gastrointestinal tract infections (bacterial and protozoal)

  • Amoebic dysentery and giardiasis

  • Dental and oral infections caused by anaerobic bacteria

  • Certain gynecological and pelvic infections

Key Information:

  • Best taken after food to reduce stomach upset.

  • Complete the full prescribed course even if symptoms improve early.

  • Avoid alcohol consumption during treatment and up to 48 hours after stopping (Ornidazole can cause severe reactions with alcohol).

  • Swallow the tablet whole with water; do not crush or chew.

Possible Side Effects:

  • Nausea, vomiting, abdominal pain

  • Metallic/bitter taste in mouth (Ornidazole)

  • Diarrhea or constipation

  • Headache, dizziness

  • Rare: tendon pain/swelling, allergic reactions, dark-colored urine (harmless with Ornidazole)

⚠️ Precautions:

  • Use with caution in patients with liver, kidney, or CNS disorders.

  • Avoid in pregnancy and breastfeeding unless prescribed.

  • Not recommended in children unless specifically advised by a doctor.

  • Avoid prolonged exposure to sunlight during Ofloxacin therapy.

Oflomac-M Forte Suspension

Oflomac-M Forte Suspension contains a combination of Ofloxacin (100mg/5ml) and Metronidazole (200mg/5ml). It is an antibiotic and antiprotozoal medicine used in children to treat a wide range of bacterial and parasitic infections, including those affecting the teeth, gums, lungs, gastrointestinal tract, urinary tract, and genital tract. It is especially effective in managing conditions like diarrhea and dysentery caused by mixed infections.

This suspension works by damaging the DNA of harmful bacteria and parasites, thereby stopping their growth and preventing the infection from spreading. With its dual-action formula, it offers broader coverage against difficult infections.

How to use:
Oflomac-M Forte Suspension is given orally, usually twice daily (morning and evening), with or without food. If your child experiences stomach upset, give it with meals. If vomiting occurs within 30 minutes of a dose, the same dose may be repeated. Always measure the dose with a proper measuring cup or spoon and shake the bottle well before use. The exact dose and duration are determined by the doctor based on your child’s age, body weight, and the severity of infection. Completing the full prescribed course is essential to prevent relapse or resistance.

Possible side effects:
Most children tolerate Oflomac-M Forte Suspension well, but some may experience nausea, vomiting, abdominal pain, diarrhea, headache, dizziness, metallic taste, loss of appetite, mild rash, urine discoloration, or difficulty sleeping (insomnia). These effects are usually mild and temporary. If they persist or worsen, consult your child’s doctor.

Precautions:
Before use, inform your doctor if your child has a history of allergies, kidney disease, liver problems, or heart conditions. Dose adjustments may be needed in cases of kidney or severe liver impairment.

Missed dose:
If a dose is missed, give it as soon as you remember unless it is nearly time for the next one. Do not double the dose to make up for the missed one.

Oflomac-M Forte Suspension

Oflomac-M Forte Suspension is a broad-spectrum combination antibiotic containing Ofloxacin (100mg/5ml) and Metronidazole (200mg/5ml). This oral suspension is designed for the treatment of moderate to severe gastrointestinal infections caused by bacteria and protozoa.

  • Ofloxacin is a fluoroquinolone antibiotic effective against a wide range of bacteria.

  • Metronidazole works against anaerobic bacteria and protozoal infections.

Together, they provide strong action against mixed bacterial and protozoal infections, especially in the gastrointestinal tract.

Common Uses:

  • Acute diarrhea and dysentery

  • Gastrointestinal infections due to mixed pathogens

  • Amoebic dysentery and giardiasis

  • Infections of gums, oral cavity, and dental abscesses

  • Gynecological and pelvic infections (as prescribed)

Key Information:

  • Shake well before use.

  • Use the prescribed measuring spoon/cup for accurate dosing.

  • Complete the full course to avoid relapse or resistance.

  • Avoid alcohol during treatment and up to 48 hours after stopping (due to Metronidazole).

Possible Side Effects:

  • Nausea, vomiting, abdominal discomfort

  • Diarrhea or constipation

  • Metallic/bitter taste in mouth (Metronidazole effect)

  • Dizziness, headache

  • Dark-colored urine (harmless effect of Metronidazole)

  • Rare: tendon pain/swelling, allergic reactions

⚠️ Precautions:

  • Dose should be carefully adjusted for children depending on weight.

  • Avoid use in pregnancy and breastfeeding unless advised by a doctor.

  • Patients with kidney, liver, or neurological disorders should be monitored closely.

  • Avoid prolonged sun exposure during Ofloxacin therapy.

Oflomac-M Suspension

Oflomac-M Suspension contains a combination of Ofloxacin (50mg/5ml) and Metronidazole (100mg/5ml). It is an antibiotic and antiprotozoal medicine used in children to treat bacterial and parasitic infections, especially those causing diarrhea, dysentery, and infections of the gastrointestinal tract, urinary tract, lungs, genital tract, and teeth.

This medicine works by damaging the DNA of harmful bacteria and parasites, thereby stopping their growth and preventing the infection from spreading. By combining two active agents, it provides broad-spectrum protection against mixed bacterial and parasitic infections.

How to use:
Oflomac-M Suspension is given orally, usually at a fixed time each day, with or without food. The dose is carefully decided by the doctor depending on your child’s age, weight, and severity of infection. Shake the bottle well before each use and measure the dose with a proper measuring cup or spoon. Ensure the full course is completed, even if symptoms improve, to prevent recurrence and resistance.

Possible side effects:
Oflomac-M Suspension is generally well tolerated, but some children may experience nausea, vomiting, abdominal cramps, diarrhea, headache, dizziness, metallic taste, loss of appetite, or temporary urine discoloration. These effects are usually mild and go away once the body adjusts to the medicine. However, if side effects persist or worsen, consult your doctor promptly.

Precautions:
Before starting this medicine, inform the doctor if your child has a history of allergy, liver problems, kidney disease, or heart conditions. Proper medical supervision helps ensure safe and effective treatment.

Missed dose:
If you miss a dose, give it as soon as you remember. If it’s almost time for the next one, skip the missed dose — do not double the dose to make up.

OKACID D

Okacid D Capsule is a combination medicine containing Domperidone 10 mg and Omeprazole 20 mg, used for the treatment of acidity, indigestion, and reflux-related conditions.

  • Omeprazole is a proton pump inhibitor (PPI) that works by reducing excess stomach acid.

  • Domperidone is a prokinetic that increases stomach and intestinal movement, helping food pass more easily and preventing nausea, vomiting, and bloating.

Uses:

  • Gastroesophageal reflux disease (GERD)

  • Persistent heartburn and acid reflux

  • Stomach ulcers caused by excessive acid

  • Indigestion and bloating

  • Nausea and vomiting due to acid reflux

Dosage and Administration:
Take Okacid D as prescribed, usually once daily before meals. The capsule should be swallowed whole with water and should not be chewed or crushed.

Common Side Effects:

  • Headache

  • Diarrhea or constipation

  • Abdominal pain, flatulence

  • Dry mouth

  • Dizziness

Side effects are generally mild and temporary. Seek medical advice if you experience severe allergic reactions, irregular heartbeat, or persistent stomach pain.

Precautions:

  • Inform your doctor if you have liver, kidney, or heart problems.

  • Avoid long-term use without medical supervision.

  • Safe use during pregnancy and breastfeeding should be decided by the doctor.

  • Limit alcohol and smoking as they worsen acid reflux.

Benefits:
Okacid D Capsule provides dual action relief—it reduces acid secretion while improving digestion and preventing reflux-related discomforts. It is especially useful for patients suffering from both acidity and nausea.

OKAMET 500 SR

Okamet 500 SR Tablet is an oral antidiabetic medicine manufactured by Cipla Ltd. It contains Metformin Hydrochloride 500mg in a sustained-release (SR) formulation, which is specially designed to release the medicine gradually over a longer period. This helps in maintaining steady blood glucose levels while reducing stomach-related side effects that are sometimes associated with immediate-release Metformin.

Metformin belongs to the biguanide class of antidiabetic drugs. It is considered the first-line therapy for the management of Type 2 Diabetes Mellitus, especially in overweight patients.


How Okamet 500 SR Works

  • Reduces glucose production in the liver (hepatic gluconeogenesis)

  • Decreases absorption of glucose from the intestine

  • Improves insulin sensitivity, allowing the body to use glucose more efficiently

The sustained-release property ensures that the medicine acts slowly and steadily, reducing the chances of gastrointestinal side effects such as diarrhea and acidity.


Uses of Okamet 500 SR Tablet

  • Management of Type 2 Diabetes Mellitus (non-insulin-dependent diabetes)

  • Helps control fasting and post-meal blood glucose levels

  • Prevents long-term diabetes complications like:

    • Diabetic nephropathy (kidney damage)

    • Diabetic neuropathy (nerve damage, tingling, numbness)

    • Diabetic retinopathy (vision problems)

    • Heart and blood vessel diseases (heart attack, stroke)

  • Sometimes prescribed in Polycystic Ovarian Syndrome (PCOS) to improve insulin sensitivity and regulate menstrual cycles (under doctor’s supervision)


Dosage & Administration

  • Taken once daily with an evening meal or as directed by the doctor.

  • Swallow whole with water, do not crush or chew as it affects the sustained-release mechanism.

  • Regular blood sugar and HbA1c monitoring are essential.


Precautions

  • Use cautiously in patients with kidney or liver impairment.

  • Avoid excessive alcohol intake due to the risk of lactic acidosis (rare but serious).

  • Not suitable for Type 1 Diabetes Mellitus or diabetic ketoacidosis.

  • Inform your doctor if you are pregnant, breastfeeding, or scheduled for surgery.


Possible Side Effects

  • Mild gastrointestinal symptoms: nausea, vomiting, diarrhea, stomach upset (less frequent than with immediate-release tablets)

  • Metallic taste or loss of appetite

  • Long-term use may lead to Vitamin B12 deficiency

  • Rare but serious: Lactic acidosis (symptoms include extreme weakness, muscle pain, abdominal pain, trouble breathing)


Overall Benefit

Okamet 500 SR Tablet provides effective blood sugar control in Type 2 Diabetes while being gentler on the stomach due to its sustained-release action. It is a preferred choice for patients who experience side effects with standard Metformin tablets. By controlling sugar levels and improving insulin sensitivity, it reduces the risk of long-term diabetic complications and enhances overall quality of life.

OKAMET GM 1002 TABS

Okamet GM 1002 Tablet is a combination oral antidiabetic medicine manufactured by Cipla Ltd. It contains Glimepiride 2mg and Metformin Hydrochloride 1000mg (Sustained Release). This combination is widely prescribed for the management of Type 2 Diabetes Mellitus, especially when diet, exercise, and single-drug therapy are not enough to control blood sugar.


How Okamet GM 1002 Works

  • Glimepiride (2mg): Belongs to the sulfonylurea class. It stimulates the pancreas to release more insulin, thereby reducing blood glucose levels, especially after meals.

  • Metformin SR (1000mg): A biguanide that works by reducing sugar production in the liver, decreasing sugar absorption from the intestines, and improving the body’s response to insulin. The sustained-release form ensures gradual absorption, providing long-lasting sugar control with fewer stomach-related side effects.

Together, these two medicines provide synergistic action for better control of both fasting and postprandial (after meal) blood glucose levels.


Uses of Okamet GM 1002 Tablet

  • Treatment of Type 2 Diabetes Mellitus in patients not controlled by lifestyle measures or single therapy.

  • Helps in controlling both fasting and post-meal sugar levels.

  • Reduces the risk of long-term complications such as:

    • Kidney damage (diabetic nephropathy)

    • Nerve problems (diabetic neuropathy)

    • Eye damage (diabetic retinopathy)

    • Heart disease and stroke

  • May help in achieving better weight control compared to sulfonylurea alone.


Dosage & Administration

  • Usually taken once daily with meals, preferably breakfast or the first main meal.

  • Should be swallowed whole with water (do not crush or chew).

  • Dosage is individualized based on blood sugar levels and doctor’s advice.

  • Regular monitoring of blood glucose and HbA1c is necessary.


Precautions

  • Not recommended in Type 1 Diabetes or diabetic ketoacidosis.

  • Use cautiously in patients with kidney or liver problems.

  • Avoid alcohol intake, as it increases the risk of lactic acidosis (from Metformin) and severe hypoglycemia (from Glimepiride).

  • Hypoglycemia risk is higher, so patients should not skip meals and must carry a sugar source (glucose tablets/candy).

  • Pregnant or breastfeeding women should take only on doctor’s advice.


Possible Side Effects

  • Hypoglycemia (sweating, shakiness, dizziness, hunger, weakness)

  • Gastrointestinal issues (nausea, diarrhea, stomach discomfort)

  • Headache or dizziness

  • Rare: Vitamin B12 deficiency with long-term Metformin use

  • Rare but serious: Lactic acidosis with Metformin


Overall Benefit

Okamet GM 1002 Tablet provides a powerful dual therapy for Type 2 Diabetes by combining Glimepiride and Metformin. It ensures strong blood sugar control throughout the day, lowers the risk of diabetes-related complications, and supports better quality of life in patients who require combination treatment.

OKAMET GM 501 TABS

Okamet GM 501 Tablet is an oral antidiabetic combination medicine manufactured by Cipla Ltd. It combines Glimepiride 1mg and Metformin Hydrochloride 500mg (Sustained Release) to provide effective management of Type 2 Diabetes Mellitus in patients who are not adequately controlled with lifestyle modifications or single-drug therapy.


How Okamet GM 501 Works

  • Glimepiride (1mg): A sulfonylurea drug that stimulates the pancreas to release more insulin, thereby reducing high blood sugar levels after meals.

  • Metformin SR (500mg): A biguanide that reduces sugar production in the liver, decreases absorption of glucose from the intestine, and improves insulin sensitivity. The sustained-release formulation ensures gradual absorption, reducing stomach-related side effects and maintaining steady blood sugar control.

This dual mechanism targets both fasting and post-meal blood glucose levels, providing more comprehensive management of diabetes.


Uses of Okamet GM 501 Tablet

  • Treatment of Type 2 Diabetes Mellitus when diet, exercise, and monotherapy are insufficient.

  • Helps lower fasting and postprandial blood glucose levels.

  • Reduces the risk of long-term complications of diabetes such as:

    • Diabetic nephropathy (kidney damage)

    • Diabetic neuropathy (nerve pain, tingling, numbness)

    • Diabetic retinopathy (eye damage/vision loss)

    • Cardiovascular diseases (heart attack, stroke)

  • Provides better control in patients requiring combination therapy at lower Glimepiride strength.


Dosage & Administration

  • Usually taken once daily with a meal, preferably breakfast or the first main meal.

  • Swallow the tablet whole with water, do not crush or chew.

  • Dosage may be adjusted based on blood glucose levels and doctor’s recommendation.

  • Regular monitoring of blood sugar and HbA1c is advised.


Precautions

  • Not for use in Type 1 Diabetes or diabetic ketoacidosis.

  • Use cautiously in patients with kidney or liver impairment.

  • Avoid alcohol as it increases the risk of lactic acidosis (from Metformin) and severe hypoglycemia (from Glimepiride).

  • Hypoglycemia is possible; patients should not skip meals and should carry a sugar source (like glucose tablets or candy).

  • Use in pregnancy or breastfeeding should be done only under medical advice.


Possible Side Effects

  • Hypoglycemia (sweating, shakiness, dizziness, weakness)

  • Nausea, diarrhea, stomach upset

  • Headache, mild dizziness

  • Long-term Metformin use may lead to Vitamin B12 deficiency

  • Rare but serious: Lactic acidosis with Metformin


Overall Benefit

Okamet GM 501 Tablet is an effective and well-balanced therapy for Type 2 Diabetes, especially suitable for patients who need combination treatment but with a lower Glimepiride dose. It provides strong glucose control, reduces the risk of complications, and improves overall health outcomes when used along with diet and exercise.

OKAMET GM 502 TABS

Okamet GM 502 Tablet is a combination oral antidiabetic medicine manufactured by Cipla Ltd. It contains Glimepiride 2mg and Metformin Hydrochloride 500mg (Sustained Release). This medicine is prescribed for the management of Type 2 Diabetes Mellitus when diet, exercise, and single therapy are not sufficient to control blood sugar levels.


How Okamet GM 502 Works

  • Glimepiride (2mg): A sulfonylurea that stimulates the pancreas to release more insulin, helping to reduce high blood sugar levels, especially after meals.

  • Metformin SR (500mg): A biguanide that reduces glucose production in the liver, delays absorption of sugar from the intestine, and enhances the body’s sensitivity to insulin. The sustained-release (SR) formulation provides longer-lasting action and reduces stomach irritation compared to immediate-release forms.

Together, these medicines provide complementary effects, giving effective control over both fasting and postprandial (after meal) blood glucose levels.


Uses of Okamet GM 502 Tablet

  • Management of Type 2 Diabetes Mellitus in patients not adequately controlled by lifestyle measures or single-drug therapy.

  • Helps in lowering fasting and post-meal sugar levels.

  • Prevents the risk of diabetes-related long-term complications such as:

    • Diabetic kidney disease (nephropathy)

    • Nerve damage (neuropathy – tingling, numbness, burning pain)

    • Eye damage (retinopathy/vision problems)

    • Cardiovascular diseases such as heart attack and stroke

  • Beneficial for patients requiring stronger glucose control with higher Glimepiride strength.


Dosage & Administration

  • Usually taken once daily with the first main meal of the day (preferably breakfast).

  • Swallow the tablet whole with water; do not crush or chew.

  • Dose adjustments depend on blood sugar levels and doctor’s recommendation.

  • Regular monitoring of blood glucose and HbA1c is necessary for effective control.


Precautions

  • Not for use in Type 1 Diabetes or diabetic ketoacidosis.

  • Caution required in patients with kidney or liver problems.

  • Avoid alcohol as it increases the risk of hypoglycemia (low blood sugar) and lactic acidosis.

  • Patients should not skip meals and should always carry a sugar source (like glucose tablets or candy) in case of hypoglycemia.

  • Should be used during pregnancy or breastfeeding only on medical advice.


Possible Side Effects

  • Hypoglycemia (sweating, shakiness, hunger, dizziness, weakness)

  • Stomach upset, nausea, diarrhea, or abdominal discomfort

  • Headache or mild dizziness

  • Long-term use may cause Vitamin B12 deficiency (due to Metformin)

  • Rare but serious: Lactic acidosis (symptoms: muscle pain, breathing difficulty, severe weakness)


Overall Benefit

Okamet GM 502 Tablet provides a powerful dual therapy for Type 2 Diabetes by combining Glimepiride and Metformin SR. It ensures effective blood sugar control throughout the day, lowers the risk of diabetes-related complications, and improves overall quality of life when taken along with a proper diet and exercise routine.

OKAMET GMP 1 TABLET

Okamet GMP 1 Tablet is a triple combination oral antidiabetic medicine manufactured by Cipla Ltd. It contains Glimepiride 1mg, Metformin Hydrochloride 500mg (Sustained Release), and Pioglitazone 15mg. This medicine is prescribed for the management of Type 2 Diabetes Mellitus when diet, exercise, and dual therapy do not provide adequate control.


How Okamet GMP 1 Works

  • Glimepiride (1mg): A sulfonylurea that increases insulin secretion from the pancreas, lowering blood glucose after meals.

  • Metformin SR (500mg): A biguanide that reduces glucose production in the liver, delays sugar absorption from the intestines, and enhances insulin sensitivity in the body.

  • Pioglitazone (15mg): A thiazolidinedione that improves the body’s response to insulin, allowing better glucose utilization in muscles and fat tissues.

Together, these three medicines act through different mechanisms to provide powerful and comprehensive blood sugar control, targeting both fasting and postprandial (after meal) glucose levels.


Uses of Okamet GMP 1 Tablet

  • Management of Type 2 Diabetes Mellitus in patients not adequately controlled with diet, exercise, and dual therapy.

  • Helps in controlling fasting and post-meal sugar levels.

  • Prevents or delays complications of uncontrolled diabetes such as:

    • Diabetic neuropathy (nerve damage causing tingling, numbness, burning sensation)

    • Diabetic nephropathy (kidney damage leading to protein in urine)

    • Diabetic retinopathy (eye damage and vision loss)

    • Cardiovascular diseases (heart attack, stroke)

  • Provides strong control for patients requiring triple-drug therapy.


Dosage & Administration

  • Usually taken once daily with a main meal, preferably breakfast.

  • Swallow the tablet whole with water; do not crush or chew.

  • Dose is individualized based on blood glucose levels and doctor’s advice.

  • Regular monitoring of blood sugar, HbA1c, kidney and liver function tests is necessary.


Precautions

  • Not suitable for Type 1 Diabetes or diabetic ketoacidosis.

  • Use cautiously in patients with heart failure, liver disease, or kidney problems (due to Pioglitazone and Metformin).

  • Avoid alcohol as it increases the risk of lactic acidosis and severe hypoglycemia.

  • May cause fluid retention or weight gain (due to Pioglitazone).

  • Should be used in pregnancy or breastfeeding only under strict medical supervision.


Possible Side Effects

  • Hypoglycemia (sweating, dizziness, hunger, weakness)

  • Stomach upset, nausea, diarrhea (from Metformin)

  • Weight gain, fluid retention, or ankle swelling (from Pioglitazone)

  • Headache or dizziness

  • Rare but serious: Lactic acidosis, liver dysfunction, or worsening of heart failure


Overall Benefit

Okamet GMP 1 Tablet offers a triple mechanism of action by combining Glimepiride, Metformin SR, and Pioglitazone, making it highly effective in controlling Type 2 Diabetes when dual therapy is insufficient. It helps maintain stable sugar levels throughout the day, reduces the risk of long-term complications, and supports improved overall health and quality of life.

OKAMET GMP 2 TABLET

Okamet GMP 2 Tablet is a triple-drug oral antidiabetic formulation manufactured by Cipla Ltd. It contains Glimepiride 2mg, Metformin Hydrochloride 500mg (Sustained Release), and Pioglitazone 15mg. This medicine is prescribed to patients with Type 2 Diabetes Mellitus whose blood glucose is not adequately controlled with dual therapy or lifestyle modifications alone.

It provides comprehensive glycemic control by targeting different pathways responsible for high blood sugar, making it highly effective for long-term diabetes management.


How Okamet GMP 2 Works

  • Glimepiride (2mg): A sulfonylurea that stimulates the pancreas to release more insulin, thereby reducing high blood sugar after meals.

  • Metformin SR (500mg): A biguanide that lowers glucose production in the liver, delays intestinal absorption of sugar, and improves insulin sensitivity.

  • Pioglitazone (15mg): A thiazolidinedione that enhances the body’s response to insulin and improves glucose uptake in muscles and fat tissues.

This three-way mechanism ensures effective control of both fasting and postprandial (after-meal) blood glucose levels.


Uses of Okamet GMP 2 Tablet

  • Management of Type 2 Diabetes Mellitus in adults.

  • Helps control fasting and post-meal blood sugar levels.

  • Prevents the risk of diabetes-related complications such as:

    • Neuropathy (nerve damage)

    • Nephropathy (kidney damage)

    • Retinopathy (eye damage)

    • Cardiovascular complications (heart disease, stroke).

  • Useful for patients needing triple-drug therapy when single or dual drug therapy is not enough.


Dosage & Administration

  • Usually taken once daily with a meal (preferably breakfast or as directed by doctor).

  • Swallow whole with water; do not crush or chew.

  • Dose is individualized based on blood glucose levels and patient’s response.

  • Regular monitoring of blood sugar, HbA1c, kidney, and liver function is essential.


Precautions

  • Not for Type 1 Diabetes or diabetic ketoacidosis.

  • Caution in patients with heart failure, kidney or liver impairment.

  • Avoid alcohol (increases risk of lactic acidosis and hypoglycemia).

  • May cause weight gain and fluid retention (due to Pioglitazone).

  • Not recommended during pregnancy or breastfeeding unless advised by a doctor.


Possible Side Effects

  • Hypoglycemia (sweating, tremors, dizziness, weakness, hunger)

  • Gastrointestinal upset: nausea, vomiting, diarrhea (from Metformin)

  • Weight gain, fluid retention, ankle swelling (from Pioglitazone)

  • Headache or dizziness

  • Rare but serious: Lactic acidosis, liver dysfunction, or worsening of heart failure


Overall Benefit

Okamet GMP 2 Tablet provides a powerful triple-action therapy for effective control of Type 2 Diabetes. By combining Glimepiride, Metformin SR, and Pioglitazone, it helps achieve stable blood sugar control, reduces long-term diabetes complications, and improves the overall quality of life for patients needing intensive management.

Oleptal OD 450 Tablet SR

OPTANOL-450 SR contains oxcarbazepine 450 mg in a sustained release (SR) formulation, used for long-term, steady control of certain types of seizures in epilepsy. The SR tablet allows for stable, prolonged blood levels, often with once-daily dosing for improved adherence.

Clinical Uses

  • Monotherapy or adjunctive therapy for partial-onset (focal) seizures in adults and children (above 4–6 years, as directed).

  • May reduce frequency and severity of generalized tonic-clonic seizures, as part of epilepsy management.

  • Sometimes used for trigeminal neuralgia, neuropathic pain, and off-label psychiatric uses if prescribed by a doctor.

Mechanism of Action

  • Oxcarbazepine blocks voltage-gated sodium channels in nerve cells, suppressing the abnormal brain activity that causes seizures.

  • Also modulates calcium and potassium channels, stabilizing neuronal firing and reducing excitability.

Dosage & Administration

  • Usually taken once or twice daily, as advised, at the same time(s) each day.

  • Swallow whole—do not crush or chew sustained-release tablets.

  • Continue regular dosing and do not stop suddenly to prevent seizure risk.

Common Side Effects

  • Drowsiness, dizziness, headache, nausea, vomiting, tiredness, blurred/double vision, coordination problems, rash

  • Hyponatremia (low sodium), allergic reactions, mood/mental changes may occur and require medical attention.

Precautions & Safety Advice

  • Caution in kidney/liver disease, low sodium, psychiatric conditions, pregnancy, or breastfeeding.

  • Regular blood tests for sodium, liver function, and blood counts may be advised for long-term use.

  • May impair alertness and coordination—avoid hazardous activities until response is known.

OPTANOL-450 SR is a sustained-release anticonvulsant tablet for the reliable, daily management of epilepsy and seizure disorders.